NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Last Close
Jul 03 04:00PM ET
157.70
Dollar change
+0.23
Percentage change
0.15
%
CategoryGlobal or ExUS Equities - Industry Sector Asset TypeEquities (Stocks) TagsU.S. Return% 1Y-6.37% Total Holdings26 Perf Week3.25%
SponsorVan Eck Associates Corporation ETF Type Tagsequity Return% 3Y2.95% AUM340.09M Perf Month4.67%
Fund Family Bond Type Tagstechnology Return% 5Y-0.13% NAV/sh Perf Quarter1.22%
IndexMVIS US Listed Biotech 25 Index Average Maturity Tagsbiotechnology Return% 10Y 52W High183.64 -14.13% Perf Half Y0.88%
Index Weighting Commodity Type Tagsmid-cap Return% SI 52W Low135.34 16.52% Perf YTD0.47%
Active/Passive Quant Type Tags- Flows% 1M-2.59% Volatility1.25% 1.12% Perf Year-6.37%
Dividend TTM1.25 (0.79%) ESG Type Tags- Flows% 3M-6.84% ATR (14)2.11 Perf 3Y8.14%
Dividend Ex-DateDec 23, 2024 Dividend Type Sector/Theme Flows% YTD-14.52% RSI (14)64.88 Perf 5Y-2.07%
Dividend Gr. 3/5Y46.65% 21.54% Structure Type Region Flows% 1Y Beta0.73 Perf 10Y14.51%
Expense0.35% Growth/Value SMA202.58% Flows% 3Y Rel Volume0.48 Prev Close157.47
Inverse/Leveraged Market Cap SMA505.09% Flows% 5Y Avg Volume14.19K Price157.70
IPODec 21, 2011 Option/ShortYes / Yes SMA200-1.97% Trades Volume6,745 Change0.15%
Jun-30-25 06:20AM
May-02-25 03:25AM
Apr-30-25 04:35AM
Apr-29-25 06:20AM
Apr-23-25 05:45AM
01:40PM Loading…
Apr-18-25 01:40PM
Apr-04-25 08:30AM
Apr-02-25 07:00AM
Apr-01-25 05:40AM
Mar-29-25 12:50AM
Mar-28-25 06:05AM
Mar-20-25 04:32PM
Dec-20-24 08:56PM
Dec-15-23 07:57PM
Apr-06-23 08:58AM
02:00PM Loading…
Aug-18-22 02:00PM
Jan-31-22 09:38PM
Jan-18-22 01:38PM
Jan-13-22 01:38PM
Jun-30-20 04:26PM
Jun-28-20 04:51PM
Jun-02-20 04:55PM
May-18-20 03:42PM
Feb-27-20 10:43AM
Feb-11-20 05:25PM
Jan-26-20 07:17PM
Dec-25-19 11:26AM
Dec-10-19 08:33AM
Dec-06-19 01:00PM
Dec-04-19 08:32AM
02:40PM Loading…
Dec-02-19 02:40PM
Nov-26-19 07:06PM
Nov-22-19 05:15PM
Nov-21-19 12:56PM
09:40AM
Nov-11-19 02:30PM
Nov-04-19 05:05PM
01:00PM
Sep-03-19 05:46PM
Aug-27-19 10:05AM
Aug-06-19 04:22PM
Jun-26-19 11:00AM
Jun-19-19 11:49AM
May-17-19 07:00AM
May-07-19 04:57PM
Apr-24-19 04:04PM
Apr-05-19 08:00AM
Feb-25-19 10:15AM
Feb-14-19 01:00PM
Jan-24-19 01:00PM
11:34AM
Jan-04-19 10:01AM
Nov-16-18 05:52PM
Oct-17-18 11:48AM
Aug-02-18 12:55PM
Jul-06-18 01:50PM
Jun-27-18 12:15PM
Mar-19-18 04:15PM
Jan-25-18 09:55AM
Jan-10-18 05:40PM
Jan-09-18 11:55AM
Dec-15-17 06:56PM
Nov-22-17 05:30PM
Oct-03-17 06:31AM
Sep-18-17 12:36PM
Sep-11-17 12:05PM
Sep-06-17 09:30AM
Aug-30-17 06:50PM
Aug-24-17 10:36AM
Aug-22-17 02:05PM
Aug-21-17 03:11PM
Aug-03-17 08:24AM
08:15AM
Aug-01-17 10:38AM
12:26AM
Jul-14-17 09:59AM
Jul-13-17 05:33PM
Jul-11-17 07:36AM
Jun-28-17 04:32PM
Jun-23-17 02:43PM
Jun-22-17 11:17AM
Jun-16-17 07:36AM
Jun-13-17 09:06AM
May-31-17 09:54AM
May-15-17 06:00AM
May-13-17 01:14AM
May-11-17 03:52PM
May-10-17 05:08PM
04:24PM
May-03-17 02:58PM
Apr-07-17 11:03AM
Mar-13-17 05:46PM
05:46PM
Mar-08-17 07:07AM
Mar-07-17 09:58AM
Mar-02-17 02:00PM
09:05AM
Feb-10-17 08:38AM
Jan-27-17 04:30PM
Jan-11-17 04:27PM
VanEck Biotech ETF seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.